212 related articles for article (PubMed ID: 17961196)
21. Lamotrigine monotherapy compared with carbamazepine, phenytoin, or valproate monotherapy in patients with epilepsy.
Kaminow L; Schimschock JR; Hammer AE; Vuong A
Epilepsy Behav; 2003 Dec; 4(6):659-66. PubMed ID: 14698699
[TBL] [Abstract][Full Text] [Related]
22. Feasibility of antiepileptic drug withdrawal following extratemporal resective epilepsy surgery.
Menon R; Rathore C; Sarma SP; Radhakrishnan K
Neurology; 2012 Aug; 79(8):770-6. PubMed ID: 22843256
[TBL] [Abstract][Full Text] [Related]
23. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy.
Otoul C; De Smedt H; Stockis A
Epilepsia; 2007 Nov; 48(11):2111-5. PubMed ID: 17651416
[TBL] [Abstract][Full Text] [Related]
24. The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent?
Montouris G; Abou-Khalil B
Epilepsia; 2009 Sep; 50 Suppl 8():16-20. PubMed ID: 19702728
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A
Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of the first antiepileptic drug in the treatment of pediatric epilepsy.
Ma MS; Ding YX; Ying W; Fang F; Ding CH; Zou LP
Pediatr Neurol; 2009 Jul; 41(1):22-6. PubMed ID: 19520269
[TBL] [Abstract][Full Text] [Related]
27. [Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in adult patients with epilepsy resistant carbamazepine and valproate].
Jóźwiak S; Niedzielska K; Mańko E; Terczyński A
Neurol Neurochir Pol; 2000; 34(4):673-89. PubMed ID: 11105300
[TBL] [Abstract][Full Text] [Related]
28. Seizure-freedom with combination therapy in localization-related epilepsy.
Peltola J; Peltola M; Raitanen J; Keränen T; Kharazmi E; Auvinen A
Seizure; 2008 Apr; 17(3):276-80. PubMed ID: 17913516
[TBL] [Abstract][Full Text] [Related]
29. The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting.
Helmstaedter C; Witt JA
Epilepsy Behav; 2013 Feb; 26(2):182-7. PubMed ID: 23318473
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of newly diagnosed epileptic crises. A French experience].
Groupe CAROLE (Coordination Active du Réseau Observatoire Longitudinal de l'Epilepsie)
Rev Neurol (Paris); 2001 Dec; 157(12):1500-12. PubMed ID: 11924446
[TBL] [Abstract][Full Text] [Related]
31. Assessment of tolerability in elderly patients: changing to lamotrigine therapy.
Evans BK; Kustra RP; Hammer AE
Am J Geriatr Pharmacother; 2007 Jun; 5(2):112-9. PubMed ID: 17719513
[TBL] [Abstract][Full Text] [Related]
32. Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy.
Tomson T; Perucca E; Battino D
Epilepsia; 2004 Oct; 45(10):1171-5. PubMed ID: 15461670
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of health status in epilepsy using the EQ-5D questionnaire: a prospective, observational, 6-month study of adjunctive therapy with anti-epileptic drugs.
Selai CE; Trimble MR; Price MJ; Remak E
Curr Med Res Opin; 2005 May; 21(5):733-9. PubMed ID: 15969872
[TBL] [Abstract][Full Text] [Related]
34. Comparative efficacy of combination drug therapy in refractory epilepsy.
Poolos NP; Warner LN; Humphreys SZ; Williams S
Neurology; 2012 Jan; 78(1):62-8. PubMed ID: 22170887
[TBL] [Abstract][Full Text] [Related]
35. Influence of lamotrigine and topiramate on MDR1 expression in difficult-to-treat temporal lobe epilepsy.
Wang-Tilz Y; Tilz C; Wang B; Tilz GP; Stefan H
Epilepsia; 2006 Feb; 47(2):233-9. PubMed ID: 16499746
[TBL] [Abstract][Full Text] [Related]
36. Transient improvement after brief antiepileptic drug withdrawal in the epilepsy monitoring unit--possible relationship to AED tolerance.
Azar NJ; Lagrange AH; Wang L; Song Y; Abou-Khalil BW
Epilepsia; 2010 May; 51(5):811-7. PubMed ID: 20067500
[TBL] [Abstract][Full Text] [Related]
37. Uncontrolled epilepsy following discontinuation of antiepileptic drugs in seizure-free patients: a review of current clinical experience.
Schmidt D; Löscher W
Acta Neurol Scand; 2005 May; 111(5):291-300. PubMed ID: 15819708
[TBL] [Abstract][Full Text] [Related]
38. Quality of life in seizure-free patients with epilepsy on monotherapy.
Auriel E; Landov H; Blatt I; Theitler J; Gandelman-Marton R; Chistik V; Margolin N; Gross B; Parmet Y; Andelman F; Neufeld MY
Epilepsy Behav; 2009 Jan; 14(1):130-3. PubMed ID: 18926930
[TBL] [Abstract][Full Text] [Related]
39. Conversion from valproic acid onto topiramate in adolescents and adults with epilepsy.
Schreiner A; Stollhoff K; Ossig W; Unkelbach S; Lüer W; Bogdanow M; Schauble B;
Acta Neurol Scand; 2009 May; 119(5):304-12. PubMed ID: 19133865
[TBL] [Abstract][Full Text] [Related]
40. Long-term control of epileptic drop attacks with the combination of valproate, lamotrigine, and a benzodiazepine: a 'proof of concept,' open label study.
Machado VH; Palmini A; Bastos FA; Rotert R
Epilepsia; 2011 Jul; 52(7):1303-10. PubMed ID: 21729037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
